News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,261 Results
Type
Article (78273)
Company Profile (719)
Press Release (779247)
Multimedia
Podcasts (236)
Webinars (35)
Section
Business (229080)
Career Advice (3814)
Deals (39508)
Drug Delivery (180)
Drug Development (90078)
Employer Resources (207)
FDA (18322)
Job Trends (17278)
News (390701)
Policy (39078)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56424)
ALS (241)
Alzheimer's disease (1981)
Antibody-drug conjugate (ADC) (573)
Approvals (18692)
Artificial intelligence (854)
ASCO (344)
Autoimmune disease (370)
Automation (69)
Bankruptcy (406)
Best Places to Work (12634)
BIO (73)
BIOSECURE Act (23)
Biosimilars (250)
Biotechnology (442)
Bladder cancer (212)
Brain cancer (86)
Breast cancer (849)
Cancer (6669)
Cardiovascular disease (563)
Career advice (3284)
Career pathing (52)
CAR-T (390)
CDC (77)
Celiac Disease (3)
Cell therapy (1075)
Cervical cancer (57)
Clinical research (77922)
Collaboration (2422)
Commercialization (1)
Company closure (8)
Compensation (1543)
Complete response letters (107)
COVID-19 (3043)
CRISPR (127)
C-suite (1318)
Cystic fibrosis (168)
Data (8841)
Decentralized trials (3)
Denatured (92)
Depression (198)
Dermatology (99)
Diabetes (712)
Diagnostics (7615)
Digital health (69)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (427)
Drug pricing (247)
Drug shortages (39)
Duchenne muscular dystrophy (322)
Earnings (99973)
Editorial (80)
Employer branding (25)
Employer resources (175)
Events (137884)
Executive appointments (1207)
FDA (22474)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1983)
Gene editing (276)
Generative AI (83)
Gene therapy (855)
GLP-1 (1290)
Government (5539)
Grass and pollen (8)
Guidances (423)
Healthcare (21254)
Hematology (197)
HIV (98)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (359)
Immuno-oncology (116)
Indications (217)
Infectious disease (3448)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (153)
Intellectual property (326)
Interviews (751)
IPO (17901)
IRA (61)
Job creations (4996)
Job search strategy (2639)
JPM (73)
Kidney cancer (22)
Labor market (125)
Layoffs (688)
Leadership (54)
Legal (9982)
Liver cancer (111)
Longevity (37)
Lung cancer (881)
Lymphoma (483)
Machine learning (69)
Management (67)
Manufacturing (1253)
Marketing (2)
MASH (229)
Medical affairs (1)
Medical device (15272)
Medtech (15449)
Mergers & acquisitions (22925)
Metabolic disorders (1845)
mRNA (275)
Multiple sclerosis (210)
NASH (24)
Neurodegenerative disease (521)
Neuropsychiatric disorders (130)
Neuroscience (3762)
Neurotech (1)
NextGen: Class of 2026 (7667)
Non-profit (5147)
Now hiring (83)
Obesity (881)
Opinion (377)
Ovarian cancer (246)
Pain (287)
Pancreatic cancer (369)
Parkinson's disease (422)
Partnered (41)
Patents (663)
Patient recruitment (790)
Peanut (71)
People (66960)
Pharmaceutical (125)
Pharmacy benefit managers (38)
Phase 1 (24103)
Phase 2 (33993)
Phase 3 (25578)
Pipeline (10039)
Policy (404)
Postmarket research (3288)
Preclinical (10654)
Press Release (72)
Prostate cancer (351)
Psychedelics (72)
Radiopharmaceuticals (375)
Rare diseases (1297)
Real estate (7234)
Recruiting (81)
Regulatory (29801)
Reports (77)
Research institute (2768)
Resumes & cover letters (594)
Rett syndrome (44)
RNA editing (31)
RSV (100)
Schizophrenia (197)
Series A (342)
Series B (250)
Service/supplier (26)
Sickle cell disease (129)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4290)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (141)
Vaccines (1315)
Venture capital (141)
Weight loss (600)
Women's health (145)
Worklife (25)
Date
Today (98)
Last 7 days (499)
Last 30 days (2814)
Last 365 days (32742)
2026 (17066)
2025 (32657)
2024 (37902)
2023 (42563)
2022 (53927)
2021 (58718)
2020 (57662)
2019 (51312)
2018 (39094)
2017 (36867)
2016 (37815)
2015 (43846)
2014 (38587)
2013 (34725)
2012 (36582)
2011 (36632)
2010 (36178)
Location
Africa (1225)
Alabama (102)
Alaska (7)
Arizona (389)
Arkansas (16)
Asia (50812)
Australia (8724)
California (14535)
Canada (4042)
China (1614)
Colorado (625)
Connecticut (644)
Delaware (449)
Europe (116239)
Florida (2174)
Georgia (473)
Hawaii (4)
Idaho (69)
Illinois (1252)
India (104)
Indiana (673)
Iowa (26)
Japan (614)
Kansas (143)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1750)
Massachusetts (10650)
Michigan (420)
Minnesota (810)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3858)
New Mexico (35)
New York (3826)
North Carolina (1943)
North Dakota (11)
Northern California (7243)
Ohio (453)
Oklahoma (27)
Oregon (53)
Pennsylvania (2850)
Puerto Rico (33)
Rhode Island (55)
South America (1590)
South Carolina (89)
South Dakota (2)
Southern California (5719)
Tennessee (234)
Texas (2362)
United States (51938)
Utah (434)
Vermont (2)
Virginia (376)
Washington D.C. (89)
Washington State (1186)
West Virginia (4)
Wisconsin (159)
Wyoming (2)
858,261 Results for "apax partners and co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Younet AI Partners with Perpetuals.com to License and Co-Develop Forgentiq.ai Sovereign LLM and Agentic Technology Platform
Strategic Partnership Positions Both Companies at the Forefront of Institutional-Grade Digital Asset Market Infrastructure Anthropic-Broadcom Landmark Deal Securing 3.5 Gigawatts of TPU Capacity Validates the AI Infrastructure Thesis and Confirms Announced Today Vision of Enterprise-Grade Private AI as the Defining Asset Class of This Decade
April 10, 2026
·
7 min read
Press Releases
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
April 21, 2026
·
4 min read
Press Releases
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
June 11, 2026
·
5 min read
Approvals
Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher
Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to accelerate drug review.
May 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
23andMe Partners with HealthEx to Connect Medical Records with Your DNA for the Future of Personalized Medicine
May 20, 2026
·
4 min read
Vaccines
Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint
The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% efficacy against the tick-borne disease in a Phase 3 trial—but failed to hit a predetermined confidence interval.
March 23, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
June 8, 2026
·
10 min read
Press Releases
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
June 3, 2026
·
5 min read
Press Releases
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
April 17, 2026
·
3 min read
Press Releases
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
June 19, 2026
·
5 min read
1 of 85,827
Next
